Giancarlo Ripabelli
Campobasso, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Dietary bioactive compounds targeting insulin resistance: mechanisms and preventive potential.
Journal: Frontiers in nutrition
Published: June 24, 2026
From Evidence to Implementation: A SIMPIOS Multimodal, Continuous Improvement Approach to Prevent Surgical Site Infections.
Journal: Infection and drug resistance
Published: November 14, 2025
Optimizing Surgical Antibiotic Prophylaxis in the Era of Antimicrobial Resistance: A Position Paper from the Italian Multidisciplinary Society for the Prevention of Healthcare-Associated Infections (SIMPIOS).
Journal: Pathogens (Basel, Switzerland)
Published: August 30, 2025
Enterococcus faecium as an Emerging Pathogen: Molecular Epidemiology and Antimicrobial Resistance in Clinical Strains.
Journal: Pathogens (Basel, Switzerland)
Published: April 29, 2025
Hospital environment as reservoir of Pseudomonas aeruginosa in human cases: a molecular epidemiology investigation in a hospital setting in central Italy.
Journal: Letters in applied microbiology
Published: October 18, 2024
Knowledge and awareness of asbestos risk among General Practitioners: Validation of a questionnaire in an area with a high incidence of asbestos-related diseases.
Journal: Preventive medicine reports
Published: October 07, 2024
Healthcare infections and antimicrobial consumption in pre-COVID-19 era: a point prevalence survey in three hospitals in a region of Central Italy.
Journal: Journal of preventive medicine and hygiene
Published: May 17, 2023
Implementation of a centralized, web-based surveillance for healthcare associated infections among residents of long-term care facilities in Italy.
Journal: Public health in practice (Oxford, England)
Published: April 03, 2023
Genomics in Public Health Scientific evidence and prospects for integration in the prevention practice
Journal: Journal of preventive medicine and hygiene
Published: February 23, 2023
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Author's reply to correspondence.
Journal: Human vaccines & immunotherapeutics
Published: January 19, 2023
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Results from an active pharmacovigilance study in central Italy.
Journal: Human vaccines & immunotherapeutics
Published: October 31, 2022
Editorial: New omics research challenges for Public and sustainable Health.
Journal: Frontiers in microbiology
Published: October 24, 2022
Last Updated: 09/26/2026